Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled trial of dexketoprofen trometamol injection for postoperative pain
CTR20240807Phase 3Completed
- Sponsor
- Zhongrun Pharmaceutical
- Start
- Mar 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexketoprofen in postoperative pain, acute pain, sponsored by Zhongrun Pharmaceutical. Started Mar 2024; status: completed.
02
Drugs
dexketoprofen
03
Conditions
postoperative painacute pain
Beyond the preview
Go deeper on CTR20240807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240807.